You are here

selumetinib

AstraZeneca, Merck win quick OK for a rare disease drug — as the FDA declares it can still move fast during a crippling pandemic

Endpoints

Sat, 04/11/20 - 11:05 pm

neurofibromatosis

AstraZeneca, Merck win red carpet treatment at the FDA as a 3-time loser seeks speedy OK for rare tumors

Endpoints

Thu, 11/14/19 - 10:21 am

Failed as a Cancer Treatment - Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1

CP Wire

Fri, 08/3/18 - 09:25 am

Array Biopharma

neurofibromatosis

Failed as a Cancer Treatment - Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1

Fri, 08/3/18 - 09:23 am

Array Biopharma

AstraZeneca’s selumetinib flops in thyroid cancer, adding to list of failures

Fierce Biotech

Fri, 07/27/18 - 10:00 am

AstraZeneca owes $192M in royalties from massive Merck deal, selumetinib licensor Array argues

Fierce Pharma

Wed, 03/21/18 - 09:19 am

Array Biopharma

Will AstraZeneca plc Capture the Lung Cancer Market?

Bidness, ETC

Tue, 08/9/16 - 10:58 pm

non-small cell lung cancer

Now a two-time loser, AstraZeneca’s hopes for selumetinib dwindle after another PhIII flop

Endpoints

Tue, 08/9/16 - 11:36 am

non-small cell lung cancer

The top 10 biopharma pipeline disasters of 2015

Fierce Biotech

Fri, 10/30/15 - 09:55 am

AstraZeneca drug selumetinib fails in uveal melanoma trial

Yahoo/Reuters

Wed, 07/22/15 - 08:31 am

Opportunities in Lung Cancer Therapies

Motley Fool

Sun, 11/24/13 - 12:30 pm

non-small cell lung cancer

Array Biopharma

Clovis Oncology

Ariad Pharmaceuticals

ASCO '13: Array Drug First to be Effective Against Melanoma of the Eye

The Street

Sat, 06/1/13 - 12:44 pm

Array Biopharma

ocular melanoma

AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials

Bloomberg

Thu, 05/16/13 - 10:33 am

moxetumomab pasudotox

hairy cell leukemia

non-small cell lung cancer

Array's Up-Coming Value Enhancing Catalysts

Seeking Alpha

Wed, 04/17/13 - 10:50 am

Array Biopharma

non-small cell lung cancer

Array shares rise on lung cancer, melanoma results

Reuters

Thu, 05/17/12 - 10:32 am

Array Biopharma

Array says potential lung cancer treatment misses statistical significance in mid-stage trial

Yahoo/AP

Fri, 09/30/11 - 11:09 am